ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
+25.05%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$18.7B
AUM Growth
+$4.8B
(+35%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
10.18%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,702
New
548
Increased
855
Reduced
264
Closed
34
Top Buys
| 1 |
Amazon
AMZN
|
+$160M |
| 2 |
Microsoft
MSFT
|
+$140M |
| 3 |
Apple
AAPL
|
+$138M |
| 4 |
Carrier Global
CARR
|
+$113M |
| 5 |
Otis Worldwide
OTIS
|
+$97.3M |
Top Sells
| 1 |
Clorox
CLX
|
+$52.5M |
| 2 |
Abbott
ABT
|
+$25.4M |
| 3 |
Colgate-Palmolive
CL
|
+$25.1M |
| 4 |
Hormel Foods
HRL
|
+$23.5M |
| 5 |
Kimberly-Clark
KMB
|
+$21.5M |
Sector Composition
| 1 | Technology | 22.9% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Industrials | 11.78% |
| 4 | Financials | 10.2% |
| 5 | Healthcare | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIG
1326
DELISTED
Big Lots, Inc.
BIG
| $254K | ﹤0.01% |
+6,036
| New | +$254K |
|
1327
Kennedy-Wilson Holdings
KW
$1.22B
| $253K | ﹤0.01% |
+16,618
| New | +$253K |
|
1328
Teradata
TDC
$1.99B
| $253K | ﹤0.01% |
+12,178
| New | +$253K |
|
|
AKCA
1329
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $253K | ﹤0.01% |
18,457
+4,781
| +35% | +$65.5K |
|
1330
Chemours
CC
$2.44B
| $252K | ﹤0.01% |
16,400
+4,938
| +43% | +$75.9K |
|
1331
Erie Indemnity
ERIE
$17.3B
| $252K | ﹤0.01% |
+1,314
| New | +$252K |
|
1332
Avis
CAR
$5.48B
| $251K | ﹤0.01% |
+10,948
| New | +$251K |
|
1333
CareTrust REIT
CTRE
$7.54B
| $250K | ﹤0.01% |
+14,589
| New | +$250K |
|
1334
Clearway Energy Class C
CWEN
$3.35B
| $250K | ﹤0.01% |
+10,838
| New | +$250K |
|
1335
Topgolf Callaway Brands
MODG
$1.71B
| $250K | ﹤0.01% |
+14,272
| New | +$250K |
|
1336
Palomar
PLMR
$3.18B
| $250K | ﹤0.01% |
+2,920
| New | +$250K |
|
1337
Western Alliance Bancorporation
WAL
$9.79B
| $250K | ﹤0.01% |
+6,613
| New | +$250K |
|
1338
Corcept Therapeutics
CORT
$7.54B
| $249K | ﹤0.01% |
+14,775
| New | +$249K |
|
1339
8x8 Inc
EGHT
$286M
| $249K | ﹤0.01% |
+15,547
| New | +$249K |
|
1340
NCR Voyix
VYX
$1.73B
| $249K | ﹤0.01% |
+23,464
| New | +$249K |
|
1341
Onto Innovation
ONTO
$5.2B
| $247K | ﹤0.01% |
+7,245
| New | +$247K |
|
1342
Tenable Holdings
TENB
$3.63B
| $247K | ﹤0.01% |
+8,275
| New | +$247K |
|
1343
Cardlytics
CDLX
$49.6M
| $246K | ﹤0.01% |
+3,514
| New | +$246K |
|
1344
Glaukos
GKOS
$5.02B
| $246K | ﹤0.01% |
+6,412
| New | +$246K |
|
1345
Skywest
SKYW
$4.36B
| $246K | ﹤0.01% |
+7,541
| New | +$246K |
|
1346
Gossamer Bio
GOSS
$707M
| $245K | ﹤0.01% |
18,847
+7,247
| +62% | +$94.2K |
|
1347
Adeia
ADEA
$1.65B
| $244K | ﹤0.01% |
+62,442
| New | +$244K |
|
1348
AXIS Capital
AXS
$7.59B
| $244K | ﹤0.01% |
6,025
+686
| +13% | +$27.8K |
|
1349
Select Medical
SEM
$1.55B
| $244K | ﹤0.01% |
+30,789
| New | +$244K |
|
1350
Jefferies Financial Group
JEF
$13.5B
| $243K | ﹤0.01% |
+16,313
| New | +$243K |
|